Global contrast media market is anticipated to grow at a considerable CAGR of 6.5% during the forecast period (2024-2031). The growing demand for contrast media in the diagnosis of several diseases is a key factor driving the global market. The ongoing R&D programs and FDA approvals to identify the potential new applications of contrast media are further aiding the global market growth. For instance, in June 2023, Bayer initiated the Phase III clinical development program called QUANTI, aiming to evaluate the safety and efficacy of gadoquatrane, an investigational extracellular macrocyclic gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI). Gadoquatrane is a highly stable MRI contrast agent featuring high relativity being studied to evaluate the potential of a substantially lower gadolinium (Gd) dose for patients.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/contrast-media-market
Further, in March 2023, GE HealthCare announced the completion of Phase I subject recruitment in its early clinical development program for a first-of-its-kind manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. This manganese-based agent could broaden GE HealthCare’s portfolio of MRI contrast agents available to radiologists, providing a potential alternative in light of perceived concerns relating to gadolinium retention. The macrocyclic, extra-cellular – or general-purpose – manganese-based contrast agent has comparable relativity – the ability of a contrast agent to enhance signal intensity during an MRI scan – and is expected to be diagnostically similar to current gadolinium-based contrast agents (GBCAs).
Global Contrast Media Market Report Segment
By Type
- Iodinated Contrast Media
- Gadolinium-based Contrast Media
- Microbubble Contrast Media
- Barium-based Contrast Media
By Procedure
- X-Ray/ Computed Tomography
- Magnetic Resonance Imaging (MRI)
- Ultrasound
By Indication
- Cardiovascular Diseases
- Oncology
- Gastrointestinal Disorders
- Neurological Disorders
A full report of Contrast Media Market available @ https://www.omrglobal.com/industry-reports/contrast-media-market
Contrast Media Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Braun Melsungen AG
- Beijing Beilu Pharmaceutical Co. Ltd.
- Borregaard
- CONGRUENT PHARMACHEM PVT LTD
- CR Double-Crane Pharmaceuticals Co., Ltd
- DAIICHI SANKYO COMPANY, LTD.
- Eisai Co., Ltd
- FUJIFILM Corp.
- HANA PHARM CO., LTD.
- iMAX Diagnostic Imaging Limited
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
